ProMetic Life Sciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ProMetic Life Sciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: axial	4/10/2019 8:30:56 AM
	of 250

COMMENT — 95% decrease in Prometic's share price seems to say it all. There are many factors in the disaster, not least of which is the ongoing short campaign. A good summary of relevant information is presented by C.C. Abbott here. The conference call is transcribed here. Conference call slides are here. ___________________________ For a stock with this kind of decline, making a comeback is difficult. Yes, there's a plan -- but it's laden with contingencies and risk. In the meantime competitors have made progress, and Prometic's first-to-market opportunities, except for plasminogen, are disappearing. While there will be trading opportunities, and probably a jump in 2020, it will be ~2022 before the company hits its stride. IF it ever does.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next